Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance Study of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

NCT06186375 is registered in ClinicalTrials.gov with CEN Biotech as lead sponsor.

NCT NCT06186375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance Study of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis
Lead sponsor
CEN Biotech
Phase
Observational
Overall status
Active, not recruiting
Start date
May 5, 2023
Completion date
March 31, 2026
Enrollment
239 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

polyarthritis; rheumatoid